IN2013CH04023A - - Google Patents

Download PDF

Info

Publication number
IN2013CH04023A
IN2013CH04023A IN4023CH2013A IN2013CH04023A IN 2013CH04023 A IN2013CH04023 A IN 2013CH04023A IN 4023CH2013 A IN4023CH2013 A IN 4023CH2013A IN 2013CH04023 A IN2013CH04023 A IN 2013CH04023A
Authority
IN
India
Prior art keywords
ticagrelor
preparation
relates
present
ecofriendly
Prior art date
Application number
Other languages
English (en)
Inventor
Velayudhan Nair Subha
Ravindra Babu Bollu
Kumar Dalasingh Prasanta
Sunil Kumar Indukuri Venkata
Ramanjaneyulu Gorantla Seeta
Original Assignee
Laurus Labs Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Pvt Ltd filed Critical Laurus Labs Pvt Ltd
Priority to IN4023CH2013 priority Critical patent/IN2013CH04023A/en
Priority to PCT/IN2014/000587 priority patent/WO2015037016A2/en
Publication of IN2013CH04023A publication Critical patent/IN2013CH04023A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
IN4023CH2013 2013-09-10 2014-09-10 IN2013CH04023A (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN4023CH2013 IN2013CH04023A (hu) 2013-09-10 2014-09-10
PCT/IN2014/000587 WO2015037016A2 (en) 2013-09-10 2014-09-10 An improved process for the preparation of ticagrelor and intermediates thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4023CH2013 IN2013CH04023A (hu) 2013-09-10 2014-09-10

Publications (1)

Publication Number Publication Date
IN2013CH04023A true IN2013CH04023A (hu) 2015-08-07

Family

ID=52666472

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4023CH2013 IN2013CH04023A (hu) 2013-09-10 2014-09-10

Country Status (2)

Country Link
IN (1) IN2013CH04023A (hu)
WO (1) WO2015037016A2 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015162630A1 (en) 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
CN106243108A (zh) * 2015-06-03 2016-12-21 四川海思科制药有限公司 一种高纯度的替格瑞洛及其制备方法
KR101787449B1 (ko) 2016-07-29 2017-10-18 주식회사 종근당 티카그렐러의 신규 염 및 이의 제조방법
CN106478636B (zh) * 2016-08-30 2019-02-15 山东罗欣药业集团恒欣药业有限公司 替格瑞洛晶型及制备方法
WO2020021110A1 (en) 2018-07-27 2020-01-30 Krka, D.D., Novo Mesto Pharmaceutical composition of ticagrelor
CN110437237A (zh) * 2019-09-06 2019-11-12 上海汇伦生命科技有限公司 一种1,2-二醇化合物单一结晶的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
ES2558843T3 (es) * 2008-09-09 2016-02-09 Astrazeneca Ab Procedimiento para preparar [1S-[1-alfa,2-alfa,3-beta(1S*,2R*),5-beta]]-3-[7-[2-(3,4-difluorofenil)-ciclopropilamino]-5-(propiltio)-3H-1,2,3-triazolo[4,5-d]pirimidin-3-il]-5-(2-hidroxietoxi)ciclopentano-1,2-diol y a sus productos intermedios
CA2832570A1 (en) * 2011-04-06 2012-10-11 Teva Pharmaceutical Industries Ltd. New intermediates and processes for preparing ticagrelor

Also Published As

Publication number Publication date
WO2015037016A3 (en) 2015-06-04
WO2015037016A2 (en) 2015-03-19

Similar Documents

Publication Publication Date Title
IN2013CH04023A (hu)
HK1259061A1 (zh) 用於純碳產生的工藝、組合物和其方法
MX370649B (es) Proceso para la preparacion de teneligliptina.
EP3152163A4 (en) Urea to ammonia process
EP2970061A4 (en) IMPROVED INTEGRATED PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUORPROPES
IN2015KN00323A (hu)
IN2013MU00646A (hu)
IN2014MU00455A (hu)
EP3014628B8 (en) Process of generating germanium-68
IN2013MU03070A (hu)
EP3008675A4 (en) Distributed worker-sourced process engineering
IN2013MU01113A (hu)
HUE040536T2 (hu) Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
PL2883461T3 (pl) Sposób wytwarzania aktywnej folistatyny
PL3153575T3 (pl) Mikroorganizm mający zdolność wytwarzania o-sukcynylohomoseryny lub kwasu bursztynowego oraz sposób wytwarzania kwasu bursztynowego lub o-sukcynylohomoseryny z jego użyciem
EP3089959A4 (en) Process for making ethanolamines
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU03768A (hu)
IN2013CH05865A (hu)
EP3166885A4 (en) Process for producing hydrogen
EP3089960A4 (en) Process for making ethanolamines
IN2012CH02984A (hu)
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
IN2013MU02771A (hu)